Nepal G, Kharel S, Coghlan MA, Rayamajhi P, et al. Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte
glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A
systematic review and meta-analysis. J Neuroimmunol 2022;364:577812.
PMID: 35063726